Cargando…

Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis

Background Prednisolone is considered the cornerstone treatment for severe alcoholic hepatitis (AH). However, its use is limited by the increased risk of infection in an already immunocompromised patient population. Among patients with severe AH, there exists a group of non-responders who do not ben...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu Omar, Yazan, Randhawa, Tejinder, Attar, Bashar, Agrawal, Rohit, Wang, Yuchen, Pichardo, Rayli, Majeed, Muhammad B, Patel, Sanjay A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907713/
https://www.ncbi.nlm.nih.gov/pubmed/31886076
http://dx.doi.org/10.7759/cureus.6141
_version_ 1783478582716137472
author Abu Omar, Yazan
Randhawa, Tejinder
Attar, Bashar
Agrawal, Rohit
Wang, Yuchen
Pichardo, Rayli
Majeed, Muhammad B
Patel, Sanjay A
author_facet Abu Omar, Yazan
Randhawa, Tejinder
Attar, Bashar
Agrawal, Rohit
Wang, Yuchen
Pichardo, Rayli
Majeed, Muhammad B
Patel, Sanjay A
author_sort Abu Omar, Yazan
collection PubMed
description Background Prednisolone is considered the cornerstone treatment for severe alcoholic hepatitis (AH). However, its use is limited by the increased risk of infection in an already immunocompromised patient population. Among patients with severe AH, there exists a group of non-responders who do not benefit from prednisolone therapy. Day-4 Lille score is a widely employed prognostic model used to identify this non-responder subgroup. The present study evaluates the prognostic ability of the inflammatory marker, the neutrophil-lymphocyte ratio (NLR), as a stand-alone model and in conjunction with the day-4 Lille score. Methods We retrospectively reviewed the electronic medical records of patients diagnosed with AH. Demographic and biochemical data at diagnosis were collected to calculate Maddrey’s discriminant function (MDF) and model for end-stage liver disease (MELD) score upon admission and also on day 4. Receiver operating characteristic (ROC) curves were plotted for day-4 NLR and day-4 Lille score for prediction of 90-day mortality, and optimal cut-off values were determined. Patients were then subcategorized into groups based on the generated optimal cut-off values. Categorization was validated by comparing the mortality rate in each group with the chi-squared test. We then performed a multivariate analysis for prediction of 90-day mortality using day-4 Lille score and day-4 NLR, constructing a new prediction score based on the odds ratio (OR). The ROC curve of the new score was plotted and the area under a curve (AUC) was reported and compared with previously validated scores. Results Our analysis demonstrated that both day-4 NLR and Lille score individually predicted 90-day mortality with statistical significance (p: 0.049, p: <0.001, respectively). The ROC analysis of day-4 Lille score for the prediction of 90-day mortality revealed an AUC of 0.819 with an optimal cut-off value of 0.45 (sensitivity: 83.3%, specificity: 76.1%). Day-4 NLR had an AUC of 0.756 with an optimal cut-off value of 12.3 (sensitivity: 66.7%, specificity: 78.1%) The combined day-Lille-NLR model with a cut-off of 0.55 had an AUC of .889, which was higher than day-4 Lille score and NLR independently. Conclusion Day-4 NLR is an easily assessed prognostic model of mortality in alcoholic hepatitis. However, it often underperforms relative to day-4 Lille score. Combining these two models to create a "modified" Lille score adds increased performance characteristics to the prediction of outcomes/mortality. The "modified" Lille score presented in this study can be used to further cut down the number of non-responders who are often forced to undergo costly and potentially harmful treatment courses.
format Online
Article
Text
id pubmed-6907713
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-69077132019-12-29 Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis Abu Omar, Yazan Randhawa, Tejinder Attar, Bashar Agrawal, Rohit Wang, Yuchen Pichardo, Rayli Majeed, Muhammad B Patel, Sanjay A Cureus Internal Medicine Background Prednisolone is considered the cornerstone treatment for severe alcoholic hepatitis (AH). However, its use is limited by the increased risk of infection in an already immunocompromised patient population. Among patients with severe AH, there exists a group of non-responders who do not benefit from prednisolone therapy. Day-4 Lille score is a widely employed prognostic model used to identify this non-responder subgroup. The present study evaluates the prognostic ability of the inflammatory marker, the neutrophil-lymphocyte ratio (NLR), as a stand-alone model and in conjunction with the day-4 Lille score. Methods We retrospectively reviewed the electronic medical records of patients diagnosed with AH. Demographic and biochemical data at diagnosis were collected to calculate Maddrey’s discriminant function (MDF) and model for end-stage liver disease (MELD) score upon admission and also on day 4. Receiver operating characteristic (ROC) curves were plotted for day-4 NLR and day-4 Lille score for prediction of 90-day mortality, and optimal cut-off values were determined. Patients were then subcategorized into groups based on the generated optimal cut-off values. Categorization was validated by comparing the mortality rate in each group with the chi-squared test. We then performed a multivariate analysis for prediction of 90-day mortality using day-4 Lille score and day-4 NLR, constructing a new prediction score based on the odds ratio (OR). The ROC curve of the new score was plotted and the area under a curve (AUC) was reported and compared with previously validated scores. Results Our analysis demonstrated that both day-4 NLR and Lille score individually predicted 90-day mortality with statistical significance (p: 0.049, p: <0.001, respectively). The ROC analysis of day-4 Lille score for the prediction of 90-day mortality revealed an AUC of 0.819 with an optimal cut-off value of 0.45 (sensitivity: 83.3%, specificity: 76.1%). Day-4 NLR had an AUC of 0.756 with an optimal cut-off value of 12.3 (sensitivity: 66.7%, specificity: 78.1%) The combined day-Lille-NLR model with a cut-off of 0.55 had an AUC of .889, which was higher than day-4 Lille score and NLR independently. Conclusion Day-4 NLR is an easily assessed prognostic model of mortality in alcoholic hepatitis. However, it often underperforms relative to day-4 Lille score. Combining these two models to create a "modified" Lille score adds increased performance characteristics to the prediction of outcomes/mortality. The "modified" Lille score presented in this study can be used to further cut down the number of non-responders who are often forced to undergo costly and potentially harmful treatment courses. Cureus 2019-11-13 /pmc/articles/PMC6907713/ /pubmed/31886076 http://dx.doi.org/10.7759/cureus.6141 Text en Copyright © 2019, Abu Omar et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Abu Omar, Yazan
Randhawa, Tejinder
Attar, Bashar
Agrawal, Rohit
Wang, Yuchen
Pichardo, Rayli
Majeed, Muhammad B
Patel, Sanjay A
Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
title Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
title_full Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
title_fullStr Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
title_full_unstemmed Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
title_short Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis
title_sort prognostic value of neutrophil-lymphocyte ratio in patients with severe alcoholic hepatitis
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907713/
https://www.ncbi.nlm.nih.gov/pubmed/31886076
http://dx.doi.org/10.7759/cureus.6141
work_keys_str_mv AT abuomaryazan prognosticvalueofneutrophillymphocyteratioinpatientswithseverealcoholichepatitis
AT randhawatejinder prognosticvalueofneutrophillymphocyteratioinpatientswithseverealcoholichepatitis
AT attarbashar prognosticvalueofneutrophillymphocyteratioinpatientswithseverealcoholichepatitis
AT agrawalrohit prognosticvalueofneutrophillymphocyteratioinpatientswithseverealcoholichepatitis
AT wangyuchen prognosticvalueofneutrophillymphocyteratioinpatientswithseverealcoholichepatitis
AT pichardorayli prognosticvalueofneutrophillymphocyteratioinpatientswithseverealcoholichepatitis
AT majeedmuhammadb prognosticvalueofneutrophillymphocyteratioinpatientswithseverealcoholichepatitis
AT patelsanjaya prognosticvalueofneutrophillymphocyteratioinpatientswithseverealcoholichepatitis